Lethality in LPS-induced endotoxemia in C3H/HeCr mice is associated with prevalence of proinflammatory cytokines: lack of protective action of lactoferrin
- PMID: 15364100
- DOI: 10.1016/j.femsim.2004.04.003
Lethality in LPS-induced endotoxemia in C3H/HeCr mice is associated with prevalence of proinflammatory cytokines: lack of protective action of lactoferrin
Abstract
C3H/HeCr mice are more susceptible to infection compared with other strains. Lactoferrin (LF), a protein involved in innate defense, was shown to protect mice against lethal endotoxemia. In this investigation we attempt to explain the cause of increased susceptibility of C3H/HeCr mice to LPS and lack of protective LF action in these mice. We found that C3H/HeCr mice produced up to 5-fold more serum TNFalpha and 66% higher IFNgamma levels in response to i.v. LPS injection than the control, CBA strain. 24 h pretreatment of C3H/HeCr mice with LF did not cause inhibition of the LPS-induced TNFalpha serum levels, whereas in CBA mice LF significantly decreased TNFalpha level. IL-6 serum levels, in turn, were lowered in C3H/HeCr mice but elevated in CBA mice. That differential regulation of cytokine production by LF in C3H/HeCr mice paralleled a decreased survival after lethal LPS injection - 10% vs. 60% in control, PBS treated mice. In addition, determination of colony forming units (CFU) in livers and spleens after administration of 10(8) Escherichia coli revealed that pretreatment of CBA mice with LF caused a marked reduction of CFU in these organs, whereas in C3H/HeCr mice the changes were insignificant. These results indicate that the altered TNFalpha/IL-6 ratio in C3H/HeCr mice, as compared to control CBA mice, as well as the increased IFNgamma level, may be responsible for the increased susceptibility to endotoxemia in that substrain. We also suggest that an association exists between the LF protective effect against endotoxic sequelae and the insult-induced systemic immune response.
Similar articles
-
Enhanced clearance of Escherichia coli and Staphylococcus aureus in mice treated with cyclophosphamide and lactoferrin.Int Immunopharmacol. 2004 Sep;4(9):1149-57. doi: 10.1016/j.intimp.2004.05.002. Int Immunopharmacol. 2004. PMID: 15251111
-
IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production.J Immunol. 1997 Mar 15;158(6):2898-903. J Immunol. 1997. PMID: 9058827
-
Protective effects of lactoferrin in Escherichia coli-induced bacteremia in mice: relationship to reduced serum TNF alpha level and increased turnover of neutrophils.Inflamm Res. 2004 Jul;53(7):292-6. doi: 10.1007/s00011-004-1257-1. Epub 2004 Jun 25. Inflamm Res. 2004. PMID: 15241563
-
[Regulation of interleukin 6 (IL-6) and TNF-alpha through lactoferrin in mice].Postepy Hig Med Dosw. 1995;49(1):53-7. Postepy Hig Med Dosw. 1995. PMID: 8657618 Review. Polish.
-
[Lactoferrin--its role in defense against infection and immunotropic properties].Postepy Hig Med Dosw. 1996;50(1):33-41. Postepy Hig Med Dosw. 1996. PMID: 8778712 Review. Polish.
Cited by
-
Lactoferrin in a Context of Inflammation-Induced Pathology.Front Immunol. 2017 Nov 6;8:1438. doi: 10.3389/fimmu.2017.01438. eCollection 2017. Front Immunol. 2017. PMID: 29163511 Free PMC article. Review.
-
Lactoferrin: Balancing Ups and Downs of Inflammation Due to Microbial Infections.Int J Mol Sci. 2017 Mar 1;18(3):501. doi: 10.3390/ijms18030501. Int J Mol Sci. 2017. PMID: 28257033 Free PMC article. Review.
-
The potential for Lactoferrin to reduce SARS-CoV-2 induced cytokine storm.Int Immunopharmacol. 2021 Jun;95:107571. doi: 10.1016/j.intimp.2021.107571. Epub 2021 Mar 12. Int Immunopharmacol. 2021. PMID: 33765614 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources